The clinical relevance and prediction efficacy from therapy of tumor microenvironment related signature score in colorectal cancer
IntroductionAs the top 3 cancer in terms of incidence and mortality, the first-line treatment for CRC includes FOLFOX, FOLFIRI, Cetuximab or immunotherapy. However, the drug sensitivity of patients to regimens is different. There has been increasing evidence that immune components of TME can affect...
Main Authors: | Xiang Jun, Shengnan Gao, Lei Yu, Guiyu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1123455/full |
Similar Items
-
SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
by: Yiming Ma, et al.
Published: (2022-11-01) -
Editorial: Identifying clinically relevant transcriptional signatures and methylation profiles in the course, treatment and outcome of colorectal cancer
by: Pooneh Mokarram, et al.
Published: (2024-03-01) -
Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy
by: Jeong Eun Kim, et al.
Published: (2022-05-01) -
The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma
by: Bangting Wang, et al.
Published: (2024-01-01) -
Cuproptosis patterns and tumor immune infiltration characterization in colorectal cancer
by: Yan Du, et al.
Published: (2022-09-01)